☆ 4.8 Editorial Material

Acute-on-chronic liver failure: an early biopsy is essential?

GUT (2010)

期刊

GUT

卷 59, 期 11, 页码 1455-1456

出版社

B M J PUBLISHING GROUP

DOI: 10.1136/gut.2010.214627

关键词

-

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure

Sabrina Rueschenbaum, Sandra Ciesek, Alexander Queck, Marek Widera, Katharina Schwarzkopf, Bernhard Bruene, Christoph Welsch, Heiner Wedemeyer, Stefan Zeuzem, Andreas Weigert, Christian M. Lange

Summary: The study reveals that immune suppression occurs early in liver cirrhosis, and as ACLF develops, both innate and adaptive immune functions are progressively diminished, potentially increasing the risk of infections in patients with liver cirrhosis.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Intensive care management of acute-on-chronic liver failure

William Bernal, Constantine Karvellas, Faouzi Saliba, Fuat H. Saner, Philippe Meersseman

Summary: Acute-on-chronic liver failure syndrome involves liver function deterioration, extrahepatic organ failure, and high mortality rate, requiring rapid and coherent management in the intensive care unit to improve patient outcomes.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Novel treatment of acute and acute-on-chronic liver failure: Interleukin-22

Seonghwan Hwang, Amy Hicks, Chai Zhen Hoo, Yong Seong Kwon, Ye Eun Cho, Joanna Moore, Bin Gao

Summary: Acute liver failure (ALF) is a life-threatening condition characterized by rapidly progressing liver dysfunction, while acute-on-chronic liver failure (ACLF) occurs in patients with existing chronic liver disease. Both conditions are associated with multiple organ failure and high short-term mortality. This review discusses the causes, pathogenesis, and current treatment options for ALF and ACLF, and explores the potential therapeutic use of interleukin-22 (IL-22), a cytokine that has shown promise in protecting against organ damage and reducing bacterial infection.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Omics in acute-on-chronic liver failure

Peng Li, Xi Liang, Jinjin Luo, Jun Li

Summary: Acute-on-chronic liver failure (ACLF) is a critical clinical entity characterized by acute decompensation, organ failure, and high mortality in patients with chronic liver disease. The pathophysiology of ACLF involves systemic inflammation, immune-metabolism disorder, mitochondrial dysfunction, and microenvironment imbalance. Omics-based analytical techniques offer novel insights into the mechanisms of ACLF and can identify potential biomarkers and therapeutic targets. This paper reviews the current knowledge and recent advances in ACLF definitions, criteria, prognostic assessments, and the application of omics-based analyses in understanding ACLF biology.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Acute-on-chronic liver failure: Where do we stand?

Francois Durand, Olivier Roux, Emmanuel Weiss, Claire Francoz

Summary: Acute-on-chronic liver failure (ACLF) is a disease characterized by rapid organ failure in patients with cirrhosis, with high mortality rates. The severity of ACLF can be classified into three grades, with grade 3 showing over 70% mortality within 28 days. While infections and bleeding are common causes, around 60% of ACLF cases have unidentified precipitating factors. Identifying high-risk cirrhosis patients and managing them carefully are crucial in preventing ACLF.

LIVER INTERNATIONAL (2021)

添加到收藏夹

Review Medicine, General & Internal

Acute-on-Chronic Liver Failure in Cirrhosis

Carmine Gambino, Salvatore Piano, Paolo Angeli

Summary: ACLF is a syndrome that develops in patients with acutely decompensated chronic liver disease, characterized by high mortality, organ failures, and systemic inflammation. Different scientific societies have proposed diagnostic criteria and clinical characteristics for ACLF, along with established and experimental treatments. Further research is needed to better understand the pathophysiology of the syndrome and explore new therapies.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure

Maria Pilar Ballester, Ahmed Elshabrawi, Rajiv Jalan

Summary: Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute decompensation, organ failure, and high mortality risk. Extracorporeal liver support systems have been developed to improve outcomes, but their impact on survival remains unclear. DIALIVE, a novel liver support device, shows promise in reducing ACLF progression and is associated with faster recovery compared to standard treatment. Liver transplantation is a lifesaving option for severe ACLF patients, but careful patient selection is essential for optimal outcomes. This review discusses the current perspectives on extracorporeal liver support and liver transplantation for ACLF patients.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Review Critical Care Medicine

Acute-on-chronic liver failure: far to go-a review

Jinjin Luo, Jiaqi Li, Peng Li, Xi Liang, Hozeifa Mohamed Hassan, Richard Moreau, Jun Li

Summary: Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome characterized by acute deterioration of chronic liver disease, organ failure, and high short-term mortality. Different definitions and diagnostic criteria have been proposed in different geographic regions due to varied causes and trigger events. Predictive and prognostic scores have been developed and validated to guide clinical management. The specific pathophysiology of ACLF is uncertain but is believed to be associated with intense systemic inflammation and immune-metabolism disorder.

CRITICAL CARE (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation

Vinay Sundaram, Christina C. Lindenmeyer, Kirti Shetty, Robert S. Rahimi, Atef Al-Attar, Gianina Flocco, Brett E. Fortune, Cynthia Gong, Suryanarayana Challa, Haripriya Maddur, Janice H. Jou, Michael Kriss, Lance L. Stein, Alex H. Xiao, Ross H. Vyhmeister, Ellen W. Green, Braidie Campbell, Andrew J. Piscitello, William Cranford, Josh Levitsky, Constantine J. Karvellas

Summary: This retrospective study reviewed data from 10 centers in North America and found that patients with ACLF at liver transplantation have greater post-transplant healthcare resource utilization, including longer hospital stay, dialysis duration, discharge to a rehabilitation center, and higher 30-day readmission rates. Patients with ACLF-1, ACLF-2, and ACLF-3 had significantly longer hospital stay compared to those without ACLF. ACLF-3 was also associated with longer dialysis duration after transplantation and higher likelihood of discharge to a rehabilitation center. Bacterial infection after transplantation predicted longer hospital stay and higher 30-day readmission rates.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Should patients with acute-on-chronic liver failure grade 3 receive higher priority for liver transplantation?

Florent Artru, David Goldberg, Patrick S. Kamath

Summary: The authors debate whether patients with acute-on-chronic liver failure grade 3 (ACLF-3) should have higher liver transplant priority. They present a clinical case of a 62-year-old male with decompensated alcohol-associated cirrhosis and multiple comorbidities. The patient is at an exceedingly high risk of death without liver transplantation based on the severity of his liver disease and multiorgan failure.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

European Assoc Study Liver, Richard Moreau, Marta Tonon, Aleksander Krag, Paolo Angeli, Marina Berenguer, Annalisa Berzigotti, Javier Fernandez, Claire Francoz, Thierry Gustot, Rajiv Jalan, Maria Papp, Jonel Trebicka

Summary: Acute-on-chronic liver failure (ACLF) is a severe form of acutely decompensated cirrhosis characterized by organ system failure(s) and high short-term mortality. Patients with ACLF may benefit from liver transplantation and should be promptly stabilized for transplantation by treating identified precipitants and providing intensive care support. These guidelines aim to help clinicians recognize ACLF, make triage decisions, manage acute precipitants, support organ systems, determine futility of intensive care, and identify potential indications for liver transplantation.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Immunology

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure

Wei Wu, Shanshan Sun, Yijie Wang, Ruihong Zhao, Haotang Ren, Zhiwei Li, Hong Zhao, Yi Zhang, Jifang Sheng, Zhi Chen, Yu Shi

Summary: Patients with ACLF exhibit significant alterations in circulating neutrophils, including increased absolute neutrophil count and changes in phenotype, gene expression, and function. These alterations are associated with poor outcomes and influenced by the circulatory environment in ACLF. Inhibiting glycolysis can reverse neutrophil dysfunction in ACLF patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Myostatin is associated with the presence and development of acute-on-chronic liver failure

Astrid Ruiz-Margain, Alessandra Pohlmann, Silke Lanzerath, Melanie Langheinrich, Alejandro Campos-Murguia, Berenice M. Roman-Calleja, Robert Schierwagen, Sabine Klein, Frank Erhard Uschner, Maximilian Joseph Brol, Aldo Torre-Delgadillo, Nayelli C. Flores-Garcia, Michael Praktiknjo, Ricardo U. Macias Rodriguez, Jonel Trebicka

Summary: The levels of myostatin are associated with the development of ACLF and mortality in patients with cirrhosis, and myostatin levels decrease progressively as cirrhosis progresses.

JHEP REPORTS (2023)

添加到收藏夹

Article Virology

ETS2 alleviates acute-on-chronic liver failure by suppressing excessive inflammation

Lulu He, Qun Cai, Xi Liang, Jiaojiao Xin, Dongyan Shi, Keke Ren, Yun Li, Jiaxian Chen, Suwan Sun, Beibei Guo, Hui Yang, Bingqi Li, Shiwen Ma, Jinjin Luo, Meiqian Hu, Jiaqi Li, Wen Hu, Peng Li, Heng Yao, Jun Li, Xin Chen, Jing Jiang, Jun Li

Summary: This study aimed to clarify the molecular basis of ETS2 in HBV-ACLF pathogenesis. Transcriptome analysis showed that ETS2 expression was significantly higher in ACLF patients than in patients with chronic liver diseases and healthy subjects. Upregulated signatures of the innate immune response were observed in ACLF patients with high ETS2 expression. ETS2 is a potential prognostic biomarker of ACLF patients that alleviates liver failure by downregulating the HMGB1-/lipopolysaccharide-triggered inflammatory response.

JOURNAL OF MEDICAL VIROLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure

Sung-Eun Kim, Ji Won Park, Hyung Su Kim, Myoung-Kuk Jang, Ki Tae Suk, Dong Joon Kim

Summary: Acute-on-chronic liver failure (ACLF) is a critical syndrome with high risk of short-term mortality in patients with chronic liver disease, often triggered by proinflammatory events like infection and alcoholic hepatitis. The gut microbiome is increasingly recognized for its impact on human health and diseases, potentially playing a major role in the development of liver disease, including ACLF.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

Signe Wiese, Jens Hove, Silje Mo, Rajeshwar P. Mookerjee, Claus L. Petersen, Marianne K. Vester-Andersen, Naja D. Mygind, Jens P. Goetze, Andreas Kjaer, Emming Bendtsen, Soren Moller

LIVER INTERNATIONAL (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis

Karen Louise Thomsen, Francesco De Chiara, Krista Rombouts, Hendrik Vilstrup, Fausto Andreola, Rajeshwar P. Mookerjee, Rajiv Jalan

MEDICAL HYPOTHESES (2018)

添加到收藏夹

Correction Multidisciplinary Sciences

Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality (vol 7, 40157, 2017)

Jane Macnaughtan, Rajeshwar P. Mookerjee, Schalk van der Merwe, Rajiv Jalan

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Statins: Old drugs as new therapy for liver diseases?

Elisa Pose, Jonel Trebicka, Rajeshwar P. Mookerjee, Paolo Angeli, Pere Gines

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality

Christian Jansen, Devnandan Amar Chatterjee, Karen Louise Thomsen, Baravan Al-Kassou, Rohit Sawhney, Helen Jones, Angela Gallego-Leon, Jennifer Lehmann, Alessandra Pohlmann, Georg Nickenig, Christian P. Strassburg, Rene Andrie, Rajiv Jalan, Markus Linhart, Jonel Trebicka, Rajeshwar P. Mookerjee

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Editorial: evaluating cirrhosis progression-lessons from the heart. Authors' reply

Rajeshwar Prosad Mookerjee, Karen Louise Thomsen

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

Signe Wiese, Andrei Voiosu, Jens D. Hove, Karen Danielsen, Theodor Voiosu, Henning Gronbaek, Holger Jon Moller, Federica Genovese, Alexander Lynge Reese-Petersen, Rajeshwar P. Mookerjee, Jens Otto Clemmesen, Jens Peter Gotze, Ove Andersen, Soren Moller, Flemming Bendtsen

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Jonel Trebicka, Javier Fernandez, Maria Papp, Paolo Caraceni, Wim Laleman, Carmine Gambino, Ilaria Giovo, Frank Erhard Uschner, Cesar Jimenez, Rajeshwar Mookerjee, Thierry Gustot, Agustin Albillos, Rafael Banares, Martin Janicko, Christian Steib, Thomas Reiberger, Juan Acevedo, Pietro Gatti, William Bernal, Stefan Zeuzem, Alexander Zipprich, Salvatore Piano, Thomas Berg, Tony Bruns, Flemming Bendtsen, Minneke Coenraad, Manuela Merli, Rudolf Stauber, Heinz Zoller, Jose Presa Ramos, Cristina Sole, German Soriano, Andrea de Gottardi, Henning Gronbaek, Faouzi Saliba, Christian Trautwein, Osman Cavit Ozdogan, Sven Francque, Stephen Ryder, Pierre Nahon, Manuel Romero-Gomez, Hans Van Vlierberghe, Claire Francoz, Michael Manns, Elisabet Garcia, Manuel Tufoni, Alex Amoros, Marco Pavesi, Cristina Sanchez, Anna Curto, Carla Pitarch, Antonella Putignano, Esau Moreno, Debbie Shawcross, Ferran Aguilar, Joan Claria, Paola Ponzo, Christian Jansen, Zsuzsanna Vitalis, Giacomo Zaccherini, Boglarka Balogh, Victor Vargas, Sara Montagnese, Carlo Alessandria, Mauro Bernardi, Pere Gines, Rajiv Jalan, Richard Moreau, Paolo Angeli, Vicente Arroyo

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Management of the major complications of cirrhosis: Beyond guidelines

Juan Carlos Garcia-Pagan, Claire Francoz, Sara Montagnese, Marco Senzolo, Rajeshwar P. Mookerjee

Summary: With a growing understanding of the pathophysiology of cirrhosis and its complications, new therapies and management strategies have emerged in recent years. While many advances have helped inform current guidelines on managing key complications of cirrhosis, there are still areas where evidence is lacking or opinions are divided among practitioners. This section explores some of these controversial areas, presenting evidence for suggested management approaches beyond existing guidelines.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence

Anne Catrine Daugaard Mikkelsen, Kristoffer Kjaergaard, Rajeshwar Prosad Mookerjee, Hendrik Vilstrup, Gregers Wegener, Cecilie Bay-Richter, Karen Louise Thomsen

Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with cognitive impairment, affecting memory, attention, and daily activities. The neurobiological changes in preclinical models of NAFLD include neuroinflammation, neurodegeneration, neurotransmitter alterations, oxidative stress, and changes in proteins and synaptic density. This systematic review supports the association between NAFLD and neurobiological changes in all stages.

NEUROCHEMICAL RESEARCH (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Evaluation of CirrhoCare® - a digital health solution for home management of individuals with cirrhosis

Konstantin Kazankov, Simone Novelli, Devnandan A. Chatterjee, Alexandra Phillips, Anu Balaji, Maruthi Raja, Graham Foster, Dhiraj Tripathi, Ravan Boddu, Ravi Kumar, Rajiv Jalan, Rajeshwar P. Mookerjee

Summary: This study aimed to assess the feasibility and potential clinical benefits of remote management using CirrhoCare (R) for individuals with acutely decompensated cirrhosis. The results showed that individuals managed with CirrhoCare (R) had lower risk of re-decompensation, fewer readmissions, and shorter hospital stays. This approach warrants further investigation in larger controlled clinical trials.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery

Nadir Abbas, Jonathan Fallowfield, David Patch, Adrian J. Stanley, Raj Mookerjee, Emmanouil Tsochatzis, Joanna A. Leithead, Peter Hayes, Abhishek Chauhan, Vikram Sharma, Neil Rajoriya, Simon Bach, Thomas Faulkner, Dhiraj Tripathi

Summary: Due to the increasing incidence of cirrhosis in the UK, more patients with chronic liver disease are being considered for non-hepatic surgery. Although there was a historical reluctance to offer surgery to these patients, careful risk assessment has shown that selected patients with compensated early-stage cirrhosis can have good outcomes. However, there are well-known risks associated with surgery in these patients, such as general anesthesia, bleeding, infections, impaired wound healing, acute kidney injury, and cardiovascular compromise.

FRONTLINE GASTROENTEROLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Mechanisms and treatment approaches for ACLF

Salvatore Piano, Nadim Mahmud, Paolo Caraceni, Marta Tonon, Rajeshwar Prosad Mookerjee

Summary: Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome characterized by decompensation of cirrhosis, severe systemic inflammation and organ failures. It is often triggered by intra- and/or extrahepatic insults such as bacterial infections or alcohol-related hepatitis. The management of ACLF includes supporting organ failures, treating precipitating factors, and considering liver transplantation in severe cases.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Acute-on-chronic liver failure: definition, prognosis and management

Ahmed Amin, Rajeshwar P. Mookerjee

FRONTLINE GASTROENTEROLOGY (2020)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.